The story of Sildenafil presents a complex picture for shareholders. While the initial launch generated substantial gains, the expiration of its exclusive rights opened the avenue to off-brand versions, dramatically https://matheviri098444.xzblogs.com/82159747/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet